The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...

as it can significantly reduce new infections of HIV. 2 However, ADR and transmitted drug resistance (TDR) are possible given the encouragement to begin ART early. An increased number of countries ...

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a ...

“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...

“These incredibly positive outcomes offer new hope at a time when 40 million individuals ... “We are encouraged by these ...

New Drug Shows Promise in Clearing HIV from Brain July 25, 2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a ...

ViiV Healthcare chief medical officer Harmony Garges said: “We know taking fewer medicines is an important consideration for ...

Data from the Centers for Disease Control and Prevention released Tuesday shows meaningful declines in STI rates between 2022 ...

Results from a new study might pave the way for a longer ... The most widely used form of PrEP is a daily HIV prevention pill that contains the antiretrovirals tenofovir disoproxil fumarate ...